These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 34063104)

  • 1. Chemical Manipulation of the Endosome Trafficking Machinery: Implications for Oligonucleotide Delivery.
    Juliano RL
    Biomedicines; 2021 May; 9(5):. PubMed ID: 34063104
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Novel Family of Small Molecules that Enhance the Intracellular Delivery and Pharmacological Effectiveness of Antisense and Splice Switching Oligonucleotides.
    Wang L; Ariyarathna Y; Ming X; Yang B; James LI; Kreda SM; Porter M; Janzen W; Juliano RL
    ACS Chem Biol; 2017 Aug; 12(8):1999-2007. PubMed ID: 28703575
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Therapeutic Oligonucleotides: An Outlook on Chemical Strategies to Improve Endosomal Trafficking.
    Mangla P; Vicentini Q; Biscans A
    Cells; 2023 Sep; 12(18):. PubMed ID: 37759475
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intracellular Trafficking and Endosomal Release of Oligonucleotides: What We Know and What We Don't.
    Juliano RL
    Nucleic Acid Ther; 2018 Jun; 28(3):166-177. PubMed ID: 29708838
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The delivery of therapeutic oligonucleotides.
    Juliano RL
    Nucleic Acids Res; 2016 Aug; 44(14):6518-48. PubMed ID: 27084936
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Integrin targeted delivery of gene therapeutics.
    Juliano RL; Ming X; Nakagawa O; Xu R; Yoo H
    Theranostics; 2011 Mar; 1():211-9. PubMed ID: 21547161
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The small molecule Retro-1 enhances the pharmacological actions of antisense and splice switching oligonucleotides.
    Ming X; Carver K; Fisher M; Noel R; Cintrat JC; Gillet D; Barbier J; Cao C; Bauman J; Juliano RL
    Nucleic Acids Res; 2013 Apr; 41(6):3673-87. PubMed ID: 23396438
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High-throughput screening identifies small molecules that enhance the pharmacological effects of oligonucleotides.
    Yang B; Ming X; Cao C; Laing B; Yuan A; Porter MA; Hull-Ryde EA; Maddry J; Suto M; Janzen WP; Juliano RL
    Nucleic Acids Res; 2015 Feb; 43(4):1987-96. PubMed ID: 25662226
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Covalent conjugation of oligonucleotides with cell-targeting ligands.
    Alam MR; Ming X; Nakagawa O; Jin J; Juliano RL
    Bioorg Med Chem; 2013 Oct; 21(20):6217-23. PubMed ID: 23777829
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structure-activity relationships and cellular mechanism of action of small molecules that enhance the delivery of oligonucleotides.
    Juliano RL; Wang L; Tavares F; Brown EG; James L; Ariyarathna Y; Ming X; Mao C; Suto M
    Nucleic Acids Res; 2018 Feb; 46(4):1601-1613. PubMed ID: 29361039
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Receptors, endocytosis, and trafficking: the biological basis of targeted delivery of antisense and siRNA oligonucleotides.
    Juliano RL; Carver K; Cao C; Ming X
    J Drug Target; 2013 Jan; 21(1):27-43. PubMed ID: 23163768
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cellular uptake and intracellular trafficking of oligonucleotides: implications for oligonucleotide pharmacology.
    Juliano RL; Ming X; Carver K; Laing B
    Nucleic Acid Ther; 2014 Apr; 24(2):101-13. PubMed ID: 24383421
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quantitative Measurement of Cytosolic and Nuclear Penetration of Oligonucleotide Therapeutics.
    Deprey K; Batistatou N; Debets MF; Godfrey J; VanderWall KB; Miles RR; Shehaj L; Guo J; Andreucci A; Kandasamy P; Lu G; Shimizu M; Vargeese C; Kritzer JA
    ACS Chem Biol; 2022 Feb; 17(2):348-360. PubMed ID: 35034446
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cellular uptake and intracellular trafficking of oligonucleotides.
    Juliano RL; Carver K
    Adv Drug Deliv Rev; 2015 Jun; 87():35-45. PubMed ID: 25881722
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Peptide Conjugates of a 2'-
    Hill AC; Becker JP; Slominski D; Halloy F; Søndergaard C; Ravn J; Hall J
    ACS Omega; 2023 Oct; 8(43):40463-40481. PubMed ID: 37929104
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hyaluronan-based delivery of therapeutic oligonucleotides for treatment of human diseases.
    Ossipov DA
    Expert Opin Drug Deliv; 2019 Jun; 16(6):621-637. PubMed ID: 31072142
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cellular delivery of siRNA and antisense oligonucleotides via receptor-mediated endocytosis.
    Ming X
    Expert Opin Drug Deliv; 2011 Apr; 8(4):435-49. PubMed ID: 21381985
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Endosomal Escape of Antisense Oligonucleotides Internalized by Stabilin Receptors Is Regulated by Rab5C and EEA1 During Endosomal Maturation.
    Miller CM; Wan WB; Seth PP; Harris EN
    Nucleic Acid Ther; 2018 Apr; 28(2):86-96. PubMed ID: 29437530
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cellular uptake and intracellular trafficking of antisense and siRNA oligonucleotides.
    Juliano RL; Ming X; Nakagawa O
    Bioconjug Chem; 2012 Feb; 23(2):147-57. PubMed ID: 21992697
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Delivery of Oligonucleotide Therapeutics: Chemical Modifications, Lipid Nanoparticles, and Extracellular Vesicles.
    Bost JP; Barriga H; Holme MN; Gallud A; Maugeri M; Gupta D; Lehto T; Valadi H; Esbjörner EK; Stevens MM; El-Andaloussi S
    ACS Nano; 2021 Sep; 15(9):13993-14021. PubMed ID: 34505766
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.